temozolomide has been researched along with Adenocarcinoma Of Kidney in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Brain metastases from renal cell carcinoma (RCC) cause significant morbidity and mortality." | 2.43 | Radiation therapy in the management of brain metastases from renal cell carcinoma. ( Amato, R; Doh, LS; Paulino, AC; Teh, BS, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hribar, KC | 1 |
| Wheeler, CJ | 1 |
| Bazarov, A | 1 |
| Varshneya, K | 1 |
| Yamada, R | 1 |
| Buckley, P | 1 |
| Patil, CG | 1 |
| Polley, MY | 1 |
| Freidlin, B | 1 |
| Korn, EL | 1 |
| Conley, BA | 1 |
| Abrams, JS | 1 |
| McShane, LM | 1 |
| Park, DK | 1 |
| Ryan, CW | 1 |
| Dolan, ME | 1 |
| Vogelzang, NJ | 1 |
| Stadler, WM | 1 |
| Sunkara, U | 1 |
| Walczak, JR | 1 |
| Summerson, L | 1 |
| Rogers, T | 1 |
| Eisenberger, M | 1 |
| Denmeade, S | 1 |
| Pili, R | 1 |
| Huff, CA | 1 |
| Sinibaldi, V | 1 |
| Carducci, MA | 1 |
| Bex, A | 1 |
| Kerst, J | 1 |
| Mallo, H | 1 |
| Van Tinteren, H | 1 |
| Horenblas, S | 1 |
| De Gast, GC | 1 |
| Doh, LS | 1 |
| Amato, R | 1 |
| Paulino, AC | 1 |
| Teh, BS | 1 |
| Sawrie, SM | 1 |
| Guthrie, BL | 1 |
| Spencer, SA | 1 |
| Nordal, RA | 1 |
| Meredith, RF | 1 |
| Markert, JM | 1 |
| Cloud, GA | 1 |
| Fiveash, JB | 1 |
1 review available for temozolomide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Radiation therapy in the management of brain metastases from renal cell carcinoma.
Topics: Brain Neoplasms; Carcinoma, Renal Cell; Dacarbazine; Humans; Kidney Neoplasms; Metalloporphyrins; Ne | 2006 |
3 trials available for temozolomide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Topics: Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma, Renal Cell; Dacarbazine; Drug | 2002 |
A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2004 |
Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality T | 2005 |
3 other studies available for temozolomide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
A Simple Three-dimensional Hydrogel Platform Enables
Topics: Aged; Animals; Carcinoma, Renal Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; | 2019 |
Statistical and practical considerations for clinical evaluation of predictive biomarkers.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Dac | 2013 |
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms | 2008 |